Colorado Urology’s New CEO to Navigate Growth and Deeper Integration

DENVER, CO – August 31, 2026 – In a move that signals a significant new chapter for one of the region's top specialty practices, Colorado Urology has named Megan Rood its next Chief Executive Officer. While leadership changes are common in the dynamic healthcare sector, Rood's appointment is noteworthy not just for who she is—a seasoned executive with over two decades of experience in the local market—but for the strategic moment she arrives. Colorado Urology stands at a self-described "pivotal stage of growth," a claim substantiated by a complex web of national partnerships and a clear ambition to redefine integrated patient care in the competitive Denver metropolitan area.

For patients and providers alike, this transition raises a critical question: what does it mean to install a leader with deep local roots at the helm of a practice increasingly powered by a national strategic engine? The answer lies in the intersection of community-focused care and large-scale institutional innovation—a space where Rood’s leadership is poised to make its greatest impact.

A Leader Forged in the Colorado Market

Megan Rood is not an outsider brought in to shake things up. Her career is intrinsically tied to the Colorado healthcare landscape, with more than 20 years spent leading physician practices and ambulatory surgery centers (ASCs). This deep-seated familiarity with the region’s unique challenges and opportunities was a key factor in her selection. Dr. Ali Sarram, the practice's president, noted this explicitly, stating, "Megan brings a wealth of healthcare leadership experience, deep understanding of our market, and genuine commitment to supporting both patients and providers."

Her academic background, a dual focus on healthcare management and psychology from Regis University, further illuminates her approach. It suggests a leader who understands that successful healthcare delivery is as much about operational efficiency as it is about human connection and trust. Throughout her career, Rood has built a reputation for championing physicians, streamlining patient access, and strengthening the overall care experience. Her appointment is a clear bet that this balanced perspective is precisely what Colorado Urology needs to navigate its next phase.

In her own words, Rood’s vision is grounded in patient reality. "Patients are looking for care that is accessible, timely, and close to home, while also meeting high expectations for quality and experience," she said in the announcement. This philosophy directly confronts the fragmentation that often plagues modern healthcare. By emphasizing collaboration between physicians, specialists, and support staff, Rood aims to build on the practice’s legacy of high-quality care while ensuring the patient journey is seamless and supportive.

Steering Growth in a Pivotal Era

The phrase "pivotal stage of growth" is more than just press release jargon; it points to a significant strategic realignment happening behind the scenes. Colorado Urology is a key member of the United Urology Group (UUG), a management services organization (MSO) that provides operational support to urology practices across five states. This partnership has allowed the Denver practice to maintain its clinical independence while benefiting from the resources and scale of a larger entity.

More importantly, UUG itself is undergoing a transformation. Audax Private Equity, which has backed UUG since 2016, recently announced an agreement to sell the MSO to OneOncology, a national network of leading independent oncology practices. This transaction, expected to close by year's end, is a game-changer. It effectively places Colorado Urology within a broader, more powerful ecosystem dedicated to integrated cancer care. OneOncology’s model is built on providing community practices with the tools—from group purchasing and operational support to clinical innovation—to thrive independently.

This national backing provides the 'why' behind the ambitious growth plans. Rood is not just taking the helm of an independent urology group; she is leading a key regional player in a national strategy to build a more cohesive cancer care continuum. The move is a direct response to a Denver market populated by formidable health systems like CU Medicine, HCA HealthONE, and Denver Health. To remain a "leading independent practice," Colorado Urology must offer a level of coordinated care and technological sophistication that can compete with these giants. The alignment with OneOncology provides the capital and strategic framework to do just that.

The Patient-First Mandate in an Integrated System

Ultimately, the success of this strategy will be measured by its impact on patients. For individuals facing a urologic diagnosis, from kidney stones to prostate cancer, the care journey can be daunting. Rood's patient-first mandate, combined with the practice's expanding integrated model, aims to alleviate that burden. Colorado Urology already operates a network that includes radiation oncology services, interventional radiology, and ASCs, creating a foundation for comprehensive treatment under one umbrella.

With Rood’s leadership and the power of the OneOncology network, this model is set to deepen. The vision is one where a patient diagnosed with prostate cancer, for example, can move seamlessly from their urologist to a radiation oncologist within the same coordinated system, with shared data and a unified care team. This reduces the logistical and emotional stress on patients and their families, ensuring they feel "safe, cared for, and supported," as Rood emphasized.

This commitment to a superior patient experience is already evident in the practice’s culture. Patient reviews frequently praise the professionalism and compassion of the staff, and clinicians like Dr. Sarram are recognized as pioneers in their field, being the first in Colorado to perform advanced procedures like Aquablation for BPH. Rood's task will be to scale this culture of excellence and compassion as the organization grows. Her leadership will be critical in ensuring that as the system becomes more complex and technologically advanced, the focus remains squarely on the individual at the center of it all.